206 related articles for article (PubMed ID: 26316711)
1. Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications.
Huri HZ; Ling DY; Ahmad WA
Drug Des Devel Ther; 2015; 9():4735-49. PubMed ID: 26316711
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
Huri HZ; Lim LP; Lim SK
Drug Des Devel Ther; 2015; 9():4355-71. PubMed ID: 26300627
[TBL] [Abstract][Full Text] [Related]
3. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study.
Fu AZ; Qiu Y; Radican L; Yin DD; Mavros P
Cardiovasc Diabetol; 2010 Apr; 9():15. PubMed ID: 20409333
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
5. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
6. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
7. Is Helicobacter pylori infection associated with glycemic control in diabetics?
Dai YN; Yu WL; Zhu HT; Ding JX; Yu CH; Li YM
World J Gastroenterol; 2015 May; 21(17):5407-16. PubMed ID: 25954115
[TBL] [Abstract][Full Text] [Related]
8. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
9. Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs.
Alfayez OM; Al Yami MS; Alshibani M; Fallatah SB; Al Khushaym NM; Alsheikh R; Alkhatib N
Prim Care Diabetes; 2019 Jun; 13(3):204-211. PubMed ID: 30713085
[TBL] [Abstract][Full Text] [Related]
10. Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial.
Santamarina M; Carlson CJ
BMC Cardiovasc Disord; 2019 Mar; 19(1):60. PubMed ID: 30876392
[TBL] [Abstract][Full Text] [Related]
11. Glycemic control in Kuwaiti diabetes patients treated with glucose-lowering medication.
Abdullah A; Alkandari A; Longenecker JC; Devarajan S; Alkhatib A; Al-Wotayan R; Al-Duwairi Q; Tuomilehto J
Prim Care Diabetes; 2020 Aug; 14(4):311-316. PubMed ID: 31911041
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of various diabetes drugs on cardiovascular prognosis.
Bell DS; Patil HR; O'Keefe JH
Rev Cardiovasc Med; 2013; 14(2-4):e107-22. PubMed ID: 24448252
[TBL] [Abstract][Full Text] [Related]
13. Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study.
Rodríguez A; Reviriego J; Karamanos V; del Cañizo FJ; Vlachogiannis N; Drossinos V;
Cardiovasc Diabetol; 2011 Feb; 10():18. PubMed ID: 21314919
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.
Meloni AR; DeYoung MB; Han J; Best JH; Grimm M
Cardiovasc Diabetol; 2013 Mar; 12():48. PubMed ID: 23522121
[TBL] [Abstract][Full Text] [Related]
15. Predictors of poor glycemic control among type 2 diabetes mellitus patients treated with antidiabetic medications: A cross-sectional study in China.
Wang J; Li J; Wen C; Liu Y; Ma H
Medicine (Baltimore); 2021 Oct; 100(43):e27677. PubMed ID: 34713865
[TBL] [Abstract][Full Text] [Related]
16. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
[TBL] [Abstract][Full Text] [Related]
18. Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.
Ji Q
Clin Ther; 2017 Jun; 39(6):1244-1264. PubMed ID: 28526416
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.
Charlier S; Vavanikunnel J; Becker C; Jick SS; Meier C; Meier CR
J Clin Endocrinol Metab; 2021 Jan; 106(2):554-566. PubMed ID: 33141149
[TBL] [Abstract][Full Text] [Related]
20. A statistical model to identify determinants of glycemic control in patients with type 2 diabetes with different pharmacotherapeutic profiles.
Moura AM; Antunes M; Martins SO; Raposo JF
PLoS One; 2020; 15(7):e0235376. PubMed ID: 32629460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
